Medical Condition News

RSS

Study: Quirky fruit fly gene can help develop new weapons against cancer

Loyola University Chicago researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.

15 Jun 2012

Practical clinical tool reliable and valid in measuring severity of dementia symptoms

A new study shows that a practical clinical tool developed by researchers from the Regenstrief Institute and the Indiana University School of Medicine to measure severity of dementia symptoms is reliable and valid. The Healthy Aging Brain Care Monitor is simple, user-friendly and sensitive to change in symptoms.

15 Jun 2012

Variations in microRNA expression within breast tumors can lead to sampling bias

Certain short strands of RNA, known as microRNAs (miRNAs), have been linked to the progression and metastasis of breast cancer and may provide information about prognosis. However, studies of miRNA expression profiles often report conflicting findings. While the potential for using miRNAs in breast cancer diagnosis is promising, scientists report in a new study published online today in The Journal of Molecular Diagnostics that differences in the amount and types of miRNA within breast tumors can be misleading.

15 Jun 2012

CTC as accurate as conventional colonoscopy in detecting cancerous polyps

Computed tomographic colonography (CTC), also known as virtual colonoscopy, administered without laxatives is as accurate as conventional colonoscopy in detecting clinically significant, potentially cancerous polyps, according to a study performed jointly at the San Francisco VA Medical Center, the University of California, San Francisco and Massachusetts General Hospital.

15 Jun 2012

Roke, University of Southampton pioneer use of Xbox computer technology for stroke

The University of Southampton, in collaboration with Roke Manor Research Ltd (Roke), a Chemring company, has pioneered the use of Xbox computer technology to develop the world's first process that measures hand joint movement to help stroke patients recover manual agility at home.

15 Jun 2012

OSA independently linked with DPN in patients with type 2 diabetes mellitus

Obstructive sleep apnea (OSA) is independently associated with diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus (T2DM), according to a new study from researchers in the UK. The severity of DPN is also correlated with the degree of OSA and the severity of nocturnal hypoxemia.

15 Jun 2012

Positive top-line results from Teva’s GALA Phase III trial on RRMS

Teva Pharmaceutical Industries Ltd. today announced positive top-line results from the GALA (Glatiramer Acetate Low-Frequency Administration) Phase III clinical trial assessing the efficacy, safety and tolerability of 40 mg/1 ml glatiramer acetate injection (GA) administered subcutaneously three times a week compared to placebo in relapsing-remitting multiple sclerosis (RRMS) patients.

15 Jun 2012

Unifying theory on causes of cancer metastases

A unifying theory on the causes of cancer metastases has been proposed by Alexander R.A. Anderson, Ph.D., chair of Integrated Mathematical Oncology at Moffitt Cancer Center, and Jacob Scott, M.D., a Moffitt Radiation Oncology Program resident that is studying for his Ph.D. at the University of Oxford Centre for Mathematical Biology.

15 Jun 2012

No evidence for inherited addictive behavior

Dr. Stanton Peele's extensive research concludes that there is no evidence that biological or genetic mechanisms have been identified for addictive behavior or that addictive behavior is therefore inherited. The inherited addiction gene theory is widely used by the majority of alcohol and drug rehab programs, but Peele's research reveals that addiction is just too complicated to be contained within a simple inherited gene.

15 Jun 2012

TGen, Scottsdale Healthcare open INNO-206 Phase 2 trial for pancreatic cancer

An investigational drug that acts like a Trojan Horse to deliver cancer killing agents for pancreatic cancer is being studied at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) that treats cancer patients with promising new drugs.

15 Jun 2012

Calcium with vitamin D supplements reduces risk of mortality in seniors

A study recently published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) suggests that vitamin D-when taken with calcium-can reduce the rate of mortality in seniors, therefore providing a possible means of increasing life expectancy.

15 Jun 2012

Study reveals molecular link between aging and cancer

It has long been known that cancer is a disease of aging, but a molecular link between the two has remained elusive.

15 Jun 2012

Digoxin can protect against high blood pressure and heart failure

An ancient heart drug that's inspired the work of herbalists and poets for centuries may treat a condition that plagues millions of overstressed and overweight Americans today.

15 Jun 2012

Gore launches CQI study for DUALMESH Biomaterial to treat ventral hernia

W. L. Gore & Associates (Gore) continues its commitment to improving patient outcomes in hernia patients, with the launch of a clinical quality improvement (CQI) study for GORE DUALMESH Biomaterial in laparoscopic repair for ventral hernia patients.

15 Jun 2012

AMPK enzyme promotes survival of cancer cells: Research

A molecule thought to limit cell proliferation also helps cancer cells survive during initial tumor formation and when the wayward cells spread to other organs in the body, researchers at the University of Illinois at Chicago College of Medicine have found.

15 Jun 2012

Third Rock Ventures announces formation of Global Blood Therapeutics

Third Rock Ventures, LLC today announced the formation of Global Blood Therapeutics, Inc. and its $40.7 million Series A financing of the company.

15 Jun 2012

Skin cancer does not discriminate between skin colors

Do you have darker skin? If so, skin cancer might not be top of mind as a significant health threat, but beware – just because your skin is darker does not mean you are immune to skin cancer.

15 Jun 2012

Dyax to discontinue ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

Dyax Corp. announced today the decision to discontinue the Company's Phase 2 trial investigating ecallantide in the acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema based upon the results of an interim analysis.

15 Jun 2012

Sanovas receives U.S. patent allowance for microsurgical lung cancer technology

Sanovas, Inc., a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its first patent relating to systems and methods for the removal of unwanted biological material, such as tissue growths and tumors, in hard-to-reach bodily cavities.

15 Jun 2012

Single gene forms common link between diabetes and Alzheimer's

In recent years it became clear that people with diabetes face an ominous prospect - a far greater risk of developing Alzheimer's disease. Now researchers at The City College of New York (CCNY) have shed light on one reason why. Biology Professor Chris Li and her colleagues have discovered that a single gene forms a common link between the two diseases.

15 Jun 2012